<?xml version='1.0' encoding='utf-8'?>
<document id="19473619"><sentence text="Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction."><entity charOffset="0-9" id="DDI-PubMed.19473619.s1.e0" text="Tenofovir" /><entity charOffset="86-96" id="DDI-PubMed.19473619.s1.e1" text="diclofenac" /><pair ddi="false" e1="DDI-PubMed.19473619.s1.e0" e2="DDI-PubMed.19473619.s1.e0" /><pair ddi="false" e1="DDI-PubMed.19473619.s1.e0" e2="DDI-PubMed.19473619.s1.e1" /></sentence><sentence text="We describe an HIV1-positive patient under long-term tenofovir treatment who developed a severe, biopsy-proven, acute tubular necrosis with proximal tubule (PT) dysfunction, precipitated by the very recent start of diclofenac, a nonsteroidal antiinflammatory drug (NSAID)"><entity charOffset="53-62" id="DDI-PubMed.19473619.s2.e0" text="tenofovir" /><entity charOffset="215-225" id="DDI-PubMed.19473619.s2.e1" text="diclofenac" /><pair ddi="false" e1="DDI-PubMed.19473619.s2.e0" e2="DDI-PubMed.19473619.s2.e0" /><pair ddi="false" e1="DDI-PubMed.19473619.s2.e0" e2="DDI-PubMed.19473619.s2.e1" /></sentence><sentence text=" Recent studies show that NSAIDs not only alter glomerular filtration but also multidrug resistance protein (MRP) 4-mediated PT secretion of several substrates" /><sentence text=" Since the patient tolerated tenofovir well for several years prior to diclofenac use, our observation suggests that diclofenac interfered with tenofovir clearance, thereby favoring its nephrotoxicity"><entity charOffset="29-38" id="DDI-PubMed.19473619.s4.e0" text="tenofovir" /><entity charOffset="71-81" id="DDI-PubMed.19473619.s4.e1" text="diclofenac" /><entity charOffset="117-127" id="DDI-PubMed.19473619.s4.e2" text="diclofenac" /><entity charOffset="144-153" id="DDI-PubMed.19473619.s4.e3" text="tenofovir" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e0" e2="DDI-PubMed.19473619.s4.e0" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e0" e2="DDI-PubMed.19473619.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e0" e2="DDI-PubMed.19473619.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e0" e2="DDI-PubMed.19473619.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e1" e2="DDI-PubMed.19473619.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e1" e2="DDI-PubMed.19473619.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e1" e2="DDI-PubMed.19473619.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e2" e2="DDI-PubMed.19473619.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19473619.s4.e2" e2="DDI-PubMed.19473619.s4.e3" /></sentence><sentence text=" NSAIDs should be avoided in patients under tenofovir"><entity charOffset="44-53" id="DDI-PubMed.19473619.s5.e0" text="tenofovir" /></sentence><sentence text="" /></document>